19-08-2014, 12:14 PM
RAPSCREEN, a novel semi in-vivo organism based model was developed in-house for rapid screening of anticancer drugs/drug delivery system and has been validated using known anticancer drugs. The present study evaluated RAPSCREEN as a model to determine the synergistic activity of Tamoxifen and Anastrozole in Microemulsion drug delivery system and established the presence of estrogen receptor in the RAPSCREEN model.
RAPSCREEN, a novel semi in-vivo organism based model was developed in-house for rapid screening of anticancer drugs/drug delivery system and has been validated using known anticancer drugs. The present study evaluated RAPSCREEN as a model to determine the synergistic activity of Tamoxifen and Anastrozole in Microemulsion drug delivery system and established the presence of estrogen receptor in the RAPSCREEN model.